Geplante Studien
ProVent2
Update on the practice of mechanical ventilation in non-ARDS ICU patients (PRoVENT 2+) –
An international, multi-centre, prospective, observational ICU cohort study of the PROVEnet
Bayer - BAY 3389934
Bayer AMG An open label Phase 1b study to investigate safety, tolerability, pharmacokinetics, and pharmacodynamics of BAY3389934 in adult patients with sepsis induced coagulopathy
HLM-Langzeitoutcome
Dialyseabhängigkeit und Langzeit-Outcome nach herzchirurgischem Eingriff unter Verwendung einer Herz-Lungen-Maschine: eine multizentrische Observationsstudie
Bayer
Exploratory study to investigate the association between the onset of disseminated intravascular coagulation (DIC) and disease progression with different biomarker candidates as well as standard clinical and demographic parameters in adult patients with sepsis.